BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29629662)

  • 1. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
    Maurya L; Singh S; Rajamanickam VM; Narayan G
    Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Based Aqueous Core Nanocapsules (ACNs) for Encapsulating Hydrophillic Vinorelbine Bitartrate: Preparation, Optimization, Characterization and In vitro Safety Assessment for Intravenous Administration.
    Lakshmi ; Singh S; Vijayakumar MR; Dewangan HK
    Curr Drug Deliv; 2018; 15(9):1284-1293. PubMed ID: 30009708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
    You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
    Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exemestane encapsulated vitamin E-TPGS-polymeric nanoparticles: preparation, optimization, characterization, and in vitro cytotoxicity assessment.
    Mishra B; Padaliya R; Patel RR
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):522-534. PubMed ID: 27017970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M; Nazemiyeh H
    Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies.
    Sabapati M; Palei NN; C K AK; Molakpogu RB
    Drug Dev Ind Pharm; 2019 Apr; 45(4):577-586. PubMed ID: 30663427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
    Wan F; You J; Sun Y; Zhang XG; Cui FD; Du YZ; Yuan H; Hu FQ
    Int J Pharm; 2008 Jul; 359(1-2):104-10. PubMed ID: 18450394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
    Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
    AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
    Jain A; Sharma T; Kumar R; Katare OP; Singh B
    Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.
    Shenoy VS; Rajyaguru TH; Gude RP; Murthy RS
    J Microencapsul; 2009 Sep; 26(6):471-8. PubMed ID: 19169921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
    Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
    J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
    Zhao L; Feng SS
    J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
    Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
    Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S
    Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
    Pandey S; Patel P; Gupta A
    Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
    Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.